Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a University Hospital

Diagnostic Microbiology and Infectious Disease

Volumn 39, Issue 3, 2001, Pages 199-201

  Baddley, John W ^a   Smith, Anita M ^b   Moser, Stephen A ^b   Pappas, Peter G ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; BLOOD FLOW; CANDIDA GLABRATA; CANDIDIASIS; CONTROLLED STUDY; FUNGUS IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ANTIFUNGAL AGENTS; CANDIDA; COLONY COUNT, MICROBIAL; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; FUNGEMIA; HOSPITALS, UNIVERSITY; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0035043450     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00214-0     Document Type: Article

References (14)

1. The epidemiology of hematogenous candidiasis caused by different Candida species
2. Trends in antifungal susceptibility among Candida sp. urinary isolates from 1994 and 1998
3. Nosocomial bloodstream infections in united states hospitals: A three-year analysis
4. Epidemiology of nosocomial fungal infections, with emphasis on Candida species
5. Fungemia at a university hospital 1984-1988
6. The changing face of Candidemia: Emergence of non-C. albicans species and antifungal resistance
7. Nosocomial candidiasis: Emerging species, reservoirs, and modes of transmission
8. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program
9. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
10. National Epidemiology of Mycoses Survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
11. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections
12. Resistance of Candida species to fluconazole
13. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant recipients